Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for endometrial cancer: targeted drug BNT323 faces chemo in phase 3 trial

NCT ID NCT06340568

Disease control Sponsor: BioNTech SE Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 8 times

Summary

This Phase 3 trial tests whether the drug BNT323 (trastuzumab pamirtecan) works better than standard chemotherapy for people with recurrent endometrial cancer that expresses HER2. About 480 participants will be split into two groups based on their HER2 levels. The study measures how long the cancer stays under control and whether tumors shrink. It is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BNT323 (trastuzumab pamirtecan)
What this could lead to
If it works, this could offer a new treatment option for people with recurrent endometrial cancer that has not responded to prior therapy.
What could go wrong
This is a Phase 3 trial, but results are not guaranteed. The drug may not improve survival or could have side effects. It is only for certain HER2 levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 480 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Nov 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Are female adults (defined as ≥18 years of age or acceptable age according to local regulations at the time of voluntarily giving informed consent). * Have histologically confirmed endometrial cancer that: * Is recurrent, * Has a HER2 IHC score of 1+, 2+ (Cohort 1), or 3+ (Cohort 2) as determined by central laboratory testing for HER2 expression, and * Is not defined as a true sarcoma (i.e., leiomyosarcoma or endometrial stromal sarcoma). Note: Uterine carcinosarcoma is allowed. * Have measurable disease defined by RECIST v1.1. * Have Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1 or 2. * Have recurrent endometrial cancer and meet any of the following: * developed recurrence \<12 months from completing platinum-based chemotherapy given as adjuvant therapy for Stage I to III disease, or * developed recurrence after platinum-based chemotherapy in the recurrent/metastatic setting. * Have received prior ICI treatment (i.e., anti-programmed death 1/anti-programmed death-ligand 1) * Have a life expectancy of ≥12 weeks at screening. Key Exclusion Criteria: * Are ineligible for all options in the investigator's choice of chemotherapy arm, per local prescribing information and institutional guidelines (applicable to Cohort 1 only). * Have a history of small bowel obstruction requiring hospitalization within the past 3 months prior the first dose of study treatment. * Have an uncontrolled intercurrent illness that would limit compliance with study requirement or substantially increase risk of incurring adverse events. * Have clinically uncontrolled pleural effusion, ascites or pericardial effusion requiring drainage, or peritoneal shunt within 2 weeks prior to the first dose of study treatment. * Have a history of (non-infectious) interstitial lung disease (ILD)/pneumonitis that required steroids, have current ILD/pneumonitis, or where suspected ILD/pneumonitis cannot be ruled out by imaging at screening. * Participants with prior use of immunosuppressive medication within 14 days prior to the first dose of study treatment, except for intranasal and inhaled corticosteroids or systemic corticosteroids at doses of less than 10 mg/day of prednisone or equivalent, and topical corticosteroids. Participants receiving corticosteroids may continue if the dose is stable upon giving main informed consent. * Have a lung-specific intercurrent clinically significant illness including, but not limited to, any underlying pulmonary disorder (e.g., pulmonary emboli within 3 months prior to the first dose of study treatment, severe asthma, chronic obstructive pulmonary disorder with moderate acute exacerbations, restrictive lung disease, pulmonary fibrosis, radiation pneumonitis, significant pleural effusion etc.), or any autoimmune, connective tissue or inflammatory disorder with pulmonary involvement (i.e., rheumatoid arthritis, Sjogren's syndrome, sarcoidosis etc.), and/or prior pneumonectomy (complete). * Have uncontrolled infection requiring systemic antibiotics, antivirals, or antifungals within 2 weeks prior to the first dose of study treatment. * Have unresolved toxicities from previous anti-cancer therapy, defined as toxicities (other than alopecia, fatigue, or endocrinopathies that are well controlled) not yet resolved to Grade ≤1 or baseline. * Are pregnant or breastfeeding or are planning pregnancy during the study or within 7 months after the last dose of study treatment. * Have a history of allergies, hypersensitivities, or intolerance to study treatments (investigational medicinal products and auxiliary medicinal product) including any excipients thereof or to other monoclonal antibodies. Participants who have successfully undergone a desensitization process and are able to tolerate the drug are eligible. * Had prior treatment with topoisomerase I inhibitors, including ADCs. * Have left ventricular ejection fraction \<55% by either echocardiography or multiple-gated acquisition within 28 days prior to the first dose of study treatment. This includes participants with tissue doppler E/e' ratio \>15. NOTE: Other protocol defined Inclusion/Exclusion criteria apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometrial cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometrial cancer endometrial carcinoma endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometrial cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    191 sites in 26 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Groeninge VZW

    RECRUITING

    Kortrijk, 8500, Belgium

  • Aalborg Universit Hospital

    RECRUITING

    Aalborg, 9000, Denmark

  • Addenbrooke's Hospital

    RECRUITING

    Cambridge, CB2 0QQ, United Kingdom

  • Adelaide Oncology & Haematology

    RECRUITING

    Adelaide, 5000, Australia

  • Affiliated Hospital of Jining Medical University

    RECRUITING

    Jining, Shandong, 272029, China

  • Akademiska Sjukhuset

    RECRUITING

    Uppsala, 75185, Sweden

  • Alexandra General Hospital of Athens

    RECRUITING

    Athens, 11528, Greece

  • Anhui Provincial Hospital

    RECRUITING

    Hefei, Anhui, 230001, China

  • Aretaieio Hospital

    RECRUITING

    Athens, 11528, Greece

  • Asan Medical Center

    RECRUITING

    Seoul, 05505, South Korea

  • Azienda Ospedaliera Cannizzaro - Oncologia

    RECRUITING

    Catania, 95126, Italy

  • Azienda Ospedaliera Ordine Mauriziano Umberto I di Torino

    RECRUITING

    Torino, 10128, Italy

  • Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS

    RECRUITING

    Bologna, 40138, Italy

  • Baskent University Adana Application and Research Center

    RECRUITING

    Adana, 01120, Turkey (Türkiye)

  • Baskent University Ankara Hospital

    RECRUITING

    Ankara, 06490, Turkey (Türkiye)

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100142, China

  • Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi

    RECRUITING

    Istanbul, 34093, Turkey (Türkiye)

  • Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie

    RECRUITING

    Bialystok, 15-027, Poland

  • Bristol Haematology and Oncology Centre

    RECRUITING

    Bristol, BS2 8ED, United Kingdom

  • Broward Health Medical Center

    RECRUITING

    Fort Lauderdale, Florida, 33316, United States

  • Bács-Kiskun Vármegyei Oktatókórház

    RECRUITING

    Kecskemét, 6000, Hungary

  • CHA Bundang Medical Center

    RECRUITING

    Seongnam-si, 13496, South Korea

  • CHU Besançon Service Oncologie

    RECRUITING

    Besançon, 25000, France

  • CHU UCL Namur-Sainte-Elisabeth

    RECRUITING

    Namur, B5000, Belgium

  • Cancer Hospital of Shandong First Medical University

    RECRUITING

    Jinan, Shandong, 250117, China

  • Cancer Hospital of Shantou University Medical College

    RECRUITING

    Shantou, Guangdong, 515063, China

  • Cancer Research SA

    RECRUITING

    Adelaide, 5000, Australia

  • Carle Cancer Institute

    RECRUITING

    Urbana, Illinois, 61801, United States

  • Castle Hill Hospital

    RECRUITING

    Cottingham, HU165JQ, United Kingdom

  • Centre François Baclesse

    RECRUITING

    Caen, 14000, France

  • Centro Oncológico de Excelencia

    RECRUITING

    San Juan, 5400, Argentina

  • Centro de Investigaciones Medicas Mar del Plata

    RECRUITING

    Buenos Aires, B7600FYK, Argentina

  • Centro de Oncologia Dr. Doreski - Fundación Respirar

    RECRUITING

    Buenos Aires, 01426, Argentina

  • Charité - Campus Virchow-Klinikum

    RECRUITING

    Berlin, 13353, Germany

  • China Medical University Hospital

    RECRUITING

    Taichung, 40447, Taiwan

  • Clinique Victor Hugo - Centre Jean Bernard

    RECRUITING

    Le Mans, 72000, France

  • Cliniques Universitaires Saint-Luc

    RECRUITING

    Brussels, 1200, Belgium

  • Debreceni Egyetem

    RECRUITING

    Debrecen, 4032, Hungary

  • Dr. Abdurrahman Yurtaslan Oncology Teaching and Research Hospital

    RECRUITING

    Ankara, 06200, Turkey (Türkiye)

  • Erasmus Medisch Centrum

    RECRUITING

    Rotterdam, 3015 AA, Netherlands

  • Ewha Womans University Seoul Hospital

    RECRUITING

    Seoul, 07804, South Korea

  • Fakultní nemocnice Bulovka

    RECRUITING

    Prague, 18081, Czechia

  • Fakultní nemocnice Motol a Homolka

    RECRUITING

    Prague, 15000, Czechia

  • Fakultní nemocnice Ostrava

    RECRUITING

    Ostrava, 01790, Czechia

  • First Affiliated Hospital of Xiamen University

    RECRUITING

    Xiamen, Fujian, 361003, China

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, 00168, Italy

  • Frankston Hospital

    RECRUITING

    Melbourne, VIC 3199, Australia

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

  • Fujian Provincial Cancer Hospital

    RECRUITING

    Fuzhou, Fujian, 350014, China

  • Fundação Faculdade Regional de Medicina de São José do Rio Petro

    RECRUITING

    São José do Rio Preto, 15090-000, Brazil

  • Fundação Sao Francisco Xavier

    RECRUITING

    Ipatinga, 35162-189, Brazil

  • Gangnam Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, 06273, South Korea

  • Gansu Provincial Maternity and Child-care Hospital

    RECRUITING

    Lanzhou, Gansu, 730050, China

  • General Hospital of Kalamata

    RECRUITING

    Kalamata, 24100, Greece

  • Gosford Hospital

    RECRUITING

    Gosford, 2250, Australia

  • Guangxi Medical University Affiliated Tumor Hospital

    RECRUITING

    Nanning, Guangxi, 530200, China

  • Guy's Hospital

    RECRUITING

    London, SE1 9RT, United Kingdom

  • Gynekologicko-porodnická klinika, Fakultni nemocnice Brno

    RECRUITING

    Brno, 60200, Czechia

  • HPT São Lucas da PUCRS - UBEA

    RECRUITING

    Porto Alegre, 90610-000, Brazil

  • Hacettepe University

    RECRUITING

    Ankara, 06230, Turkey (Türkiye)

  • Hadassah Ein Kerem Medical Center

    RECRUITING

    Jerusalem, 9112001, Israel

  • Harbin Medical University Cancer Hospital

    RECRUITING

    Harbin, Heilongjiang, 150091, China

  • Health Sciences Centre

    RECRUITING

    St. John's, A1V 3V6, Canada

  • Herlev og Gentofte Hospital

    RECRUITING

    Herlev, 2730, Denmark

  • Hospital Británico de Buenos Aires

    RECRUITING

    Buenos Aires, C1280AEB, Argentina

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital Provincial del Centenario

    RECRUITING

    Rosario, S2002KDS, Argentina

  • Hospital Sirio Libanês

    RECRUITING

    São Paulo, 01308-050, Brazil

  • Hospital Universitar Donostia

    RECRUITING

    Donostia / San Sebastian, 20014, Spain

  • Hospital Universitari Vall, d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario La Paz

    RECRUITING

    Madrid, 28046, Spain

  • Hospital Universitario Ramón y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Hospital Universitario Reina Sofia

    RECRUITING

    Córdoba, 14004, Spain

  • Hospital de Clínicas de Passo Fundo

    RECRUITING

    Passo Fundo, 99010-260, Brazil

  • Hospital de Clínicas de Porto Alegre

    RECRUITING

    Porto Alegre, 90035-903, Brazil

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, 430079, China

  • Humanitas San Pio X

    RECRUITING

    Milan, 20159, Italy

  • Hôpital Nord Bâtiment Mistral

    RECRUITING

    Marseille, 13015, France

  • Hôpital Saint Louis

    RECRUITING

    Paris, 75010, France

  • IASO General Clinic

    RECRUITING

    Marousi, 151 23, Greece

  • ICO - Site Paul Papin

    RECRUITING

    Angers, 49055, France

  • ICO - Site René Gauducheau

    RECRUITING

    Saint-Herblain, 44800, France

  • IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST)

    RECRUITING

    Meldola, 47014, Italy

  • Inst D'Or de Pesquisa E Ensino

    RECRUITING

    São Paulo, 01401-002, Brazil

  • Institut Català d'Oncologia (ICO) Hospital Universitari de Girona Dr. Josep Trueta

    RECRUITING

    Girona, 17007, Spain

  • Institut Jules Bordet

    RECRUITING

    Brussels, 1070, Belgium

  • Institut de Cancérologie de Strasbourg Europe - ICANS

    RECRUITING

    Strasbourg, 67000, France

  • Instituto Valenciano de Oncología - Valencia

    RECRUITING

    Valencia, 46009, Spain

  • Instituto de Pesquisa Clínica - Hospital Moinhos de Vento

    RECRUITING

    Porto Alegre, 90035-000, Brazil

  • Intermountain Healthcare

    RECRUITING

    Murray, Utah, 84107-5701, United States

  • Investigaciones CORI S.R.L.

    RECRUITING

    La Rioja, F5300COE, Argentina

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre

    RECRUITING

    Porto Alegre, 90050-170, Brazil

  • Istanbul University Istanbul Medical Faculty

    RECRUITING

    Istanbul, 34093, Turkey (Türkiye)

  • Istituto Europeo di Oncologia

    RECRUITING

    Milan, 20141, Italy

  • Istituto Nazionale Tumori Fondazione G. Pascale

    RECRUITING

    Naples, 80131, Italy

  • Istituto Nazionale dei Tumori

    RECRUITING

    Milan, 20133, Italy

  • Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari

    RECRUITING

    Bari, 70124, Italy

  • Jewish General Hospital

    RECRUITING

    Montreal, H3T 1E2, Canada

  • Jiangxi Maternal and Child Health Hospital

    RECRUITING

    Nanchang, Jiangxi, 330006, China

  • Karolinska University Hospital

    RECRUITING

    Stockholm, 17176, Sweden

  • Keimyung Univty Dongsan Hospital

    RECRUITING

    Daegu, 42601, South Korea

  • Kliniken Essen-Mitte

    RECRUITING

    Essen, 45136, Germany

  • Klinkum Kassel

    RECRUITING

    Kassel, 34125, Germany

  • Korea University Anam Hospital

    RECRUITING

    Seoul, 02841, South Korea

  • Kuang Tien General Hospital

    RECRUITING

    Taichung, 433004, Taiwan

  • Kuopio University HPT

    RECRUITING

    Kuopio, 70210, Finland

  • LMU-Campus Innenstadt

    RECRUITING

    München, 81377, Germany

  • Lady Davis Carmel Medical Center

    RECRUITING

    Haifa, 3436212, Israel

  • Linyi Cancer Hospital

    RECRUITING

    Linyi, Shandong, 276001, China

  • MacKay Memorial Hospital_ Taipei Branch

    RECRUITING

    Taipei, 10449, Taiwan

  • Mater Hospital Brisbane

    RECRUITING

    South Brisbane, 4001, Australia

  • MedStar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Miami Valley Hospital South

    RECRUITING

    Centerville, Ohio, 45459, United States

  • Monash Health Clinical Trial Center

    RECRUITING

    Clayton, 3168, Australia

  • Mount Vermont Cancer Center

    RECRUITING

    Middlesex, HA6 2RN, United Kingdom

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

  • NYU Langone Hospital - Long Island

    RECRUITING

    Mineola, New York, 11501, United States

  • National Cancer Center

    RECRUITING

    Goyang, 10408, South Korea

  • National Cancer Centre Singapore

    RECRUITING

    Singapore, 168583, Singapore

  • National Cheng Kung University Hospital

    RECRUITING

    Tainan, 70457, Taiwan

  • Nottingham University Hospitals NHS Trust

    RECRUITING

    Nottingham, NG5 1PB, United Kingdom

  • OSF Saint Francis Medical Center

    RECRUITING

    Peoria, Illinois, 61637, United States

  • OYS Naisten poliklinikka

    RECRUITING

    Oulu, 90029, Finland

  • Obstetrics & Gynecology Hospital of Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200011, China

  • Odense University Hospital

    RECRUITING

    Odense, 5000, Denmark

  • Ohio State University

    RECRUITING

    Hilliard, Ohio, 43026, United States

  • OncoCare Cancer Centre

    RECRUITING

    Singapore, 258499, Singapore

  • Országos Onkológiai Intézet

    RECRUITING

    Budapest, 1122, Hungary

  • Oslo University Hospital

    RECRUITING

    Oslo, 0379, Norway

  • Ospedale San Raffaele

    RECRUITING

    Milan, 20132, Italy

  • Peggy & Charles Stephenson Oklahoma Cancer Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, 3000, Australia

  • Princess Margaret Cancer C

    RECRUITING

    Toronto, M5G 2M9, Canada

  • Rabin Medical Center-Beilinson Campus

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Radboud UMC

    RECRUITING

    Nijmegen, 6525 GA, Netherlands

  • Rigshospitalet

    RECRUITING

    Copenhagen, 2100, Denmark

  • Royal Cornwall Hospital

    RECRUITING

    Truro, TR1 3LJ, United Kingdom

  • Royal Devon & Exeter HPT

    RECRUITING

    Exeter, EX2 5DW, United Kingdom

  • Royal Sussex County Hospital

    RECRUITING

    Brighton, BN2 1ES, United Kingdom

  • SUNY Upstate Medical University

    RECRUITING

    Syracuse, New York, 13210, United States

  • Samsung Changwon Hospital

    RECRUITING

    Changwon, 51353, South Korea

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

  • Sanford Cancer Center

    RECRUITING

    Sioux Falls, South Dakota, 57104, United States

  • Semmelweis Egyetem

    RECRUITING

    Budapest, 1088, Hungary

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam, 13620, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

  • Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, 03722, South Korea

  • Shaare Zedek

    RECRUITING

    Jerusalem, 9103102, Israel

  • Shaare Zedek Medical Center

    RECRUITING

    Jerusalem, 9103102, Israel

  • Sheba Medical Center

    RECRUITING

    Ramat Gan, 5265601, Israel

  • Shoalhaven Cancer Care Centre

    RECRUITING

    Nowra, 2541, Australia

  • Sichuan Provincial People's Hospital

    RECRUITING

    Chengdu, Sichuan, 610072, China

  • Siedleckie Centrum Onkologii

    RECRUITING

    Siedlce, 08-110, Poland

  • Singleton Hospital

    RECRUITING

    Swansea, SA2 8QA, United Kingdom

  • Skånes Universitetssjukhus Lund

    RECRUITING

    Lund, 222 42, Sweden

  • Sourasky Medical Centre

    RECRUITING

    Tel Aviv, 642390, Israel

  • Stavanger University Hospital

    RECRUITING

    Stavanger, 4011, Norway

  • Sunshine Hospital

    RECRUITING

    Saint Albans, 3021, Australia

  • Taichung Veterans General Hospital

    RECRUITING

    Taichung, 40705, Taiwan

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, 11217, Taiwan

  • Texas Oncology, P.A.

    RECRUITING

    Tyler, Texas, 75702, United States

  • The Affiliated Hospital of Nanjing University Medical School

    RECRUITING

    Nanjing, Jiangsu, 210008, China

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    RECRUITING

    Seoul, 06591, South Korea

  • The Center of Hope Reno

    RECRUITING

    Reno, Nevada, 89511, United States

  • The First Affiliated Hospital of Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510080, China

  • The First Affiliated Hospital of Wenzhou Medical University

    RECRUITING

    Wenzhou, Zhejiang, 325015, China

  • The First Affiliated Hospital of Xian Jiaotong University

    RECRUITING

    Xi'an, Shaanxi, 710061, China

  • The First Hospital of Jilin University

    RECRUITING

    Changchun, Jilin, 130021, China

  • The Second Affiliated Hospital of Chongqing Medical University

    RECRUITING

    Chongqing, Chongqing Municipality, 400010, China

  • The Second Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, Henan, 450014, China

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 300060, China

  • Turun yliopistollinen keskussairaala

    RECRUITING

    Turku, 20521, Finland

  • UZ Leuven

    RECRUITING

    Leuven, 3000, Belgium

  • Universitaets-Frauenklinik, Tübingen

    RECRUITING

    Tübingen, 72076, Germany

  • Universitair Ziekenhuis Antwerpen (UZA)

    RECRUITING

    Edegem, 2650, Belgium

  • Universitair Ziekenhuis Gent

    RECRUITING

    Ghent, 9000, Belgium

  • University College London Hospitals

    RECRUITING

    London, NW1 2PG, United Kingdom

  • University General Hospital Attikon

    RECRUITING

    Chaïdári, 124 62, Greece

  • University Hospital Olomouc - Onkologická klinika- Fakultni

    RECRUITING

    Olomouc, 77900, Czechia

  • Vseobecna fakultni nemocnice v Praze

    RECRUITING

    Prague, 12808, Czechia

  • WK Cancer Center

    RECRUITING

    Shreveport, Louisiana, 71103, United States

  • Warwick Hospital

    RECRUITING

    Coventry, CV2 2DX, United Kingdom

  • Western General Hospital

    RECRUITING

    Edinburgh, EH4 2XU, United Kingdom

  • Wollongong Hospital

    RECRUITING

    Wollongong, 2500, Australia

  • Xiangyang Central Hospital

    RECRUITING

    Xiangyang, Hubei, 441138, China

  • Yale University School of Medicine

    RECRUITING

    New Haven, Connecticut, 06520, United States

  • Yantai Yuhuangding Hospital

    RECRUITING

    Yantai, Shandong, 264000, China

  • Zala Varmegyei Szent Rafael Korhaz

    RECRUITING

    Zalaegerszeg, 8900, Hungary

  • Zhejiang Cancer Hospital

    RECRUITING

    Hangzhou, Zhejiang, 310022, China

  • İzmir City Hospital

    RECRUITING

    Bayraklı, 35540, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.